The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-18
SponsorThe University of Texas Health Science Center at San Antonio
About this trial
Scientists do research to answer important questions which might help change or improve the way we do things in the future.
The investigators know that using Enamel Matrix Derivatives results in thicker gum tissues around teeth. This study will test to see if using EMD around implants results in thicker gum tissues around implants.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Ability of subject to understand and the willingness to sign a written informed consent document.
Males and females; Age 18 to 89 years old
Require second stage implant uncovering
In either the maxillary or mandibular arch
Disqualifiers
Pregnancy, or those planning to become pregnant
Allergy or any medical issue using EMD
Non-English speaking
Patients on anticoagulants
Trial design
Design model
Parallel
Treatments tested in this trial
Enamel Matrix Derivative
DeviceEMD is an FDA approved medical device used in periodontal procedures since 1996. It has been shown to enhance soft and hard tissue healing, increased root coverage and aid in periodontal regeneration. It's use as an adjunct during implant uncovering may increase peri-implant mucosal thickness.
Treatment groups
32 Participants
are divided into 2 treatment groupsGroup A: Group 1: Experimental Group using EMDExperimental treatment 1 intervention
Group B: Group 2: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Mucosal Thickness
Mucosal thickness at 1 and 5mm below the free gingival margin will be measured
Time frame
One month and 3 months2
Change in Keratinized mucosal width
measurement of keratinized mucosal width at one and three months after surgical uncovering of the dental implant
Time frame
One month and 3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov